Schedule 13G ownership disclosure

Kintara Therapeutics, Inc.

Security class unavailable · CUSIP: 49720K101

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
2.4100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-22-002588
Form type
SC 13G/A
Filer
TuHURA Biosciences, Inc./NV
CIK
CIK 1498382
Filed
Feb 07, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub